InsiderLens

15 Dec 2023SALEIMPEL NEUROPHARMA INC12,0660.29 USD

indirect· By: Vivo Capital Surplus Fund VIII, L.P.

19 Dec 2023SALEIMPEL NEUROPHARMA INC28,6320.08 USD

indirect· By: Vivo Capital Surplus Fund VIII, L.P.

19 Dec 2023SALEIMPEL NEUROPHARMA INC208,6570.08 USD

indirect· By: Vivo Capital Fund VIII, L.P.

15 Dec 2023SALEIMPEL NEUROPHARMA INC87,9340.29 USD

indirect· By: Vivo Capital Fund VIII, L.P.

18 Dec 2023SALEIMPEL NEUROPHARMA INC209,0290.11 USD

indirect· By: Vivo Capital Fund VIII, L.P.

18 Dec 2023SALEIMPEL NEUROPHARMA INC28,6820.11 USD

indirect· By: Vivo Capital Surplus Fund VIII, L.P.

20 Nov 2023SALEBolt Biotherapeutics, Inc.23,4430.92 USD

indirect· By: Vivo Opportunity Fund Holdings, L.P.

16 Nov 2023SALEBolt Biotherapeutics, Inc.7,5310.96 USD

indirect· By: Vivo Capital Fund VIII, L.P.

16 Nov 2023SALEBolt Biotherapeutics, Inc.1,0400.96 USD

indirect· By: Vivo Capital Surplus Fund VIII, L.P.

16 Nov 2023SALEBolt Biotherapeutics, Inc.6,4290.96 USD

indirect· By: Vivo Opportunity Fund Holdings, L.P.

20 Nov 2023SALEBolt Biotherapeutics, Inc.3,7920.92 USD

indirect· By: Vivo Capital Surplus Fund VIII, L.P.

17 Nov 2023SALEBolt Biotherapeutics, Inc.1,1340.93 USD

indirect· By: Vivo Capital Surplus Fund VIII, L.P.

17 Nov 2023SALEBolt Biotherapeutics, Inc.7,0090.93 USD

indirect· By: Vivo Opportunity Fund Holdings, L.P.

20 Nov 2023SALEBolt Biotherapeutics, Inc.27,4650.92 USD

indirect· Vivo Capital Fund VIII, L.P.

17 Nov 2023SALEBolt Biotherapeutics, Inc.8,2110.93 USD

indirect· By: Vivo Capital Fund VIII, L.P.

15 Aug 2022PURCHASETerns Pharmaceuticals, Inc.1,2182.99 USD

indirect· By: Vivo Opportunity Fund Holdings, L.P.

12 Aug 2022PURCHASETerns Pharmaceuticals, Inc.1,123,0212.98 USD

indirect· By Vivo Opportunity Fund Holdings, L.P.first after silence

16 Aug 2022PURCHASETerns Pharmaceuticals, Inc.1,500,0002.42 USD

indirect· By: Vivo Opportunity Fund Holdings, L.P.

16 Aug 2022PURCHASETerns Pharmaceuticals, Inc.1,500,0002.42 USD

indirect· By: Vivo Opportunity Fund Holdings, L.P.deriv

27 Apr 2021CONVERSIONIMPEL NEUROPHARMA INC710,190—

indirect· See footnote

27 Apr 2021CONVERSIONIMPEL NEUROPHARMA INC98,068—

indirect· See footnote

27 Apr 2021CONVERSIONIMPEL NEUROPHARMA INC474,713—

indirect· See footnote

27 Apr 2021CONVERSIONIMPEL NEUROPHARMA INC65,552—

indirect· See footnote

27 Apr 2021CONVERSIONIMPEL NEUROPHARMA INC440,119—

indirect· See footnote

27 Apr 2021CONVERSIONIMPEL NEUROPHARMA INC60,813—

indirect· See footnote

Vivo Capital Surplus Fund VIII, L.P..

Vivo Capital Surplus Fund VIII, L.P..